SLC6A3 and Parkinson disease: However, nigrostriatal dopaminergic degeneration is widely agreed to be the core PD pathological feature,1, 2 represented in the existence of a hypodopaminergic status in the midbrain with a matching loss in the dopamine transporter (DAT) and rise in the dopamine 1 (Dl) and D2 receptor densities.